1. SUMOylation of the cardiac sodium channel NaV1.5 modifies inward current and cardiac excitability.
- Author
-
Yoon, Jin-Young, Greiner, Alexander M., Jacobs, Julia S., Kim, Young-Rae, Rasmussen, Tyler P., Kutschke, William J., Matasic, Daniel S., Vikram, Ajit, Gaddam, Ravinder R., Mehdi, Haider, Irani, Kaikobad, and London, Barry
- Abstract
Decreased peak sodium current (I Na) and increased late sodium current (I Na,L), through the cardiac sodium channel Na V 1.5 encoded by SCN5A, cause arrhythmias. Many Na V 1.5 posttranslational modifications have been reported. A recent report concluded that acute hypoxia increases I Na,L by increasing a small ubiquitin-like modifier (SUMOylation) at K442-Na V 1.5. The purpose of this study was to determine whether and by what mechanisms SUMOylation alters I Na , I Na,L , and cardiac electrophysiology. SUMOylation of Na V 1.5 was detected by immunoprecipitation and immunoblotting. I Na was measured by patch clamp with/without SUMO1 overexpression in HEK293 cells expressing wild-type (WT) or K442R-Na V 1.5 and in neonatal rat cardiac myocytes (NRCMs). SUMOylation effects were studied in vivo by electrocardiograms and ambulatory telemetry using Scn5a heterozygous knockout (SCN5A
+/– ) mice and the de-SUMOylating protein SENP2 (AAV9-SENP2), AAV9-SUMO1, or the SUMOylation inhibitor anacardic acid. Na V 1.5 trafficking was detected by immunofluorescence. Na V 1.5 was SUMOylated in HEK293 cells, NRCMs, and human heart tissue. HyperSUMOylation at Na V 1.5-K442 increased I Na in NRCMs and in HEK cells overexpressing WT but not K442R-Na v 1.5. SUMOylation did not alter other channel properties including I Na,L. AAV9-SENP2 or anacardic acid decreased I Na , prolonged QRS duration, and produced heart block and arrhythmias in SCN5A+/– mice, whereas AAV9-SUMO1 increased I Na and shortened QRS duration. SUMO1 overexpression enhanced membrane localization of Na V 1.5. SUMOylation of K442-Na v 1.5 increases peak I Na without changing I Na,L , at least in part by altering membrane abundance. Our findings do not support SUMOylation as a mechanism for changes in I Na,L. Na v 1.5 SUMOylation may modify arrhythmic risk in disease states and represents a potential target for pharmacologic manipulation. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF